SEARCH

SEARCH BY CITATION

  • 1
    Trombetta, E. S. and Mellman, I., Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 2005. 23: 9751028.
  • 2
    Wernersson, S., Karlsson, M. C., Dahlstrom, J., Mattsson, R., Verbeek, J. S. and Heyman, B., IgG-mediated enhancement of antibody responses is low in Fc receptor γ chain-deficient mice and increased in FcγRII-deficient mice. J. Immunol. 1999. 163: 618622.
  • 3
    Manca, F., Fenoglio, D., Li Pira, G., Kunkl, A. and Celada, F., Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 1991. 173: 3748.
  • 4
    Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T. et al., Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999. 189: 371380.
  • 5
    Snider, D. P., Kaubisch, A. and Segal, D. M., Enhanced antigen immunogenicity induced by bispecific antibodies. J. Exp. Med. 1990. 171: 19571963.
  • 6
    Heijnen, I. A., van Vugt, M. J., Fanger, N. A., Graziano, R. F., de Wit, T. P., Hofhuis, F. M., Guyre, P. M. et al., Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 1996. 97: 331338.
  • 7
    Gosselin, E. J., Wardwell, K., Gosselin, D. R., Alter, N., Fisher, J. L. and Guyre, P. M., Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 1992. 149: 34773481.
  • 8
    Keler, T., Guyre, P. M., Vitale, L. A., Sundarapandiyan, K., van De Winkel, J. G., Deo, Y. M. and Graziano, R. F., Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J. Immunol. 2000. 165: 67386742.
  • 9
    Zaghouani, H., Steinman, R., Nonacs, R., Shah, H., Gerhard, W. and Bona, C., Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 1993. 259: 224227.
  • 10
    Brumeanu, T. D., Bot, A., Bona, C. A., Dehazya, P., Wolf, I. and Zaghouani, H., Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology 1996. 2: 8595.
  • 11
    Gessner, J. E., Heiken, H., Tamm, A. and Schmidt, R. E., The IgG Fc receptor family. Ann. Hematol. 1998. 76: 231248.
  • 12
    Raghavan, M. and Bjorkman, P. J., Fc receptors and their interactions with immunoglobulins. Annu. Rev. Cell Dev. Biol. 1996. 12: 181220.
  • 13
    Mechetina, L. V., Najakshin, A. M., Alabyev, B. Y., Chikaev, N. A. and Taranin, A. V., Identification of CD16-2, a novel mouse receptor homologous to CD16/FcγRIII. Immunogenetics 2002. 54: 463468.
  • 14
    Nimmerjahn, F., Bruhns, P., Horiuchi, K. and Ravetch, J. V., FcγRIV: A novel FcR with distinct IgG subclass specificity. Immunity 2005. 23: 4151.
  • 15
    Nimmerjahn, F. and Ravetch, J. V., Fcγ receptors: Old friends and new family members. Immunity 2006. 24: 1928.
  • 16
    Daeron, M., Fc receptor biology. Annu. Rev. Immunol. 1997. 15: 203234.
  • 17
    Barnes, N., Gavin, A. L., Tan, P. S., Mottram, P., Koentgen, F. and Hogarth, P. M., FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 2002. 16: 379389.
  • 18
    Ioan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M., van Lent, P. L., Hofhuis, F. M., van Ojik, H. H., Sedlik, C. et al., FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002. 16: 391402.
  • 19
    Yada, A., Ebihara, S., Matsumura, K., Endo, S., Maeda, T., Nakamura, A., Akiyama, K. et al., Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell. Immunol. 2003. 225: 2132.
  • 20
    de Jong, J. M., Schuurhuis, D. H., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T. W., Ossendorp, F., Toes, R. E. et al., Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. Mol. Immunol. 2006. 43: 20452050.
  • 21
    Kalergis, A. M. and Ravetch, J. V., Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 2002. 195: 16531659.
  • 22
    Guriec, N., Daniel, C., Le Ster, K., Hardy, E. and Berthou, C., Cytokine-regulated expression and inhibitory function of FcγRIIB1 and -B2 receptors in human dendritic cells. J. Leukoc. Biol. 2006. 79: 5970.
  • 23
    White, D. M., Jensen, M. A., Shi, X., Qu, Z. and Arnason, B. G., Design and expression of polymeric immunoglobulin fusion proteins: A strategy for targeting low-affinity Fcγ receptors. Protein Expr. Purif. 2001. 21: 446455.
  • 24
    Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R. and Winter, G., Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 1988. 332: 563564.
  • 25
    Morgan, A., Jones, N. D., Nesbitt, A. M., Chaplin, L., Bodmer, M. W. and Emtage, J. S., The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, FcγRI and FcγRIII binding. Immunology 1995. 86: 319324.
  • 26
    Lund, J., Winter, G., Jones, P. T., Pound, J. D., Tanaka, T., Walker, M. R., Artymiuk, P. J. et al., Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J. Immunol. 1991. 147: 26572662.
  • 27
    Minghetti, P. P., Ruffner, D. E., Kuang, W. J., Dennison, O. E., Hawkins, J. W., Beattie, W. G. and Dugaiczyk, A., Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J. Biol. Chem. 1986. 261: 67476757.
  • 28
    Kenney, J. S., Hughes, B. W., Masada, M. P. and Allison, A. C., Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods 1989. 121: 157166.
  • 29
    Marusic-Galesic, S., Pavelic, K. and Pokric, B., Cellular immune response to the antigen administered as an immune complex. Immunology 1991. 72: 526531.
  • 30
    Marusic-Galesic, S., Marusic, M. and Pokric, B., Cellular immune response to the antigen administered as an immune complex in vivo. Immunology 1992. 75: 325329.
  • 31
    Liao, F., Shin, H. S. and Rhee, S. G., Tyrosine phosphorylation of phospholipase C-γ1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells. Proc. Natl. Acad. Sci. USA 1992. 89: 36593663.
  • 32
    Wernersson, S., Kleinau, S. and Heyman, B., Immune complex-mediated enhancement of antibody responses without induction of delayed-type hypersensitivity. Scand. J. Immunol. 2000. 52: 563569.
  • 33
    Getahun, A., Dahlstrom, J., Wernersson, S. and Heyman, B., IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fcγ receptors. J. Immunol. 2004. 172: 52695276.
  • 34
    Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F. et al., Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 2002. 168: 926932.
  • 35
    Martin, M., Michalek, S. M. and Katz, J., Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect. Immun. 2003. 71: 24982507.
  • 36
    Jiang, Y., Hirose, S., Abe, M., Sanokawa-Akakura, R., Ohtsuji, M., Mi, X., Li, N. et al., Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000. 51: 429435.
  • 37
    Brumeanu, T. D., Swiggard, W. J., Steinman, R. M., Bona, C. A. and Zaghouani, H., Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J. Exp. Med. 1993. 178: 17951799.
  • 38
    Masihi, K. N., Lange, W., Brehmer, W. and Ribi, E., Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 1986. 8: 339345.
  • 39
    Leenaars, M., Koedam, M. A., Hendriksen, C. F. and Claassen, E., Immune responses and side effects of five different oil-based adjuvants in mice. Vet. Immunol. Immunopathol. 1998. 61: 291304.
  • 40
    Jarvis, D. L., Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 2003. 310: 17.
  • 41
    Dong, X., Storkus, W. J. and Salter, R. D., Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 1999. 163: 54275434.
  • 42
    Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J., Verbeek, J. S. et al., Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 2002. 168: 22402246.
  • 43
    Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156159.
  • 44
    Martin, R. M., Brady, J. L. and Lew, A. M., The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 1998. 212: 187192.
  • 45
    Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S. and Tsurushita, N., An engineered human IgG1 antibody with longer serum half-life. J. Immunol. 2006. 176: 346356.